Fake version of ‘The Next Ozempic’ for sale on Chinese website
Knock-off versions of Eli Lilly’s retatrutide, hailed as a potential ‘New Ozempic’, are being sold directly to US consumers through Chinese websites Unapproved drugs are also finding their way to consumers through advertising on social media platforms and even partnerships with influencers. Knock-off versions of Eli Lilly’s retatrutide, hailed as a potential ‘New Ozempic,’ are … Read more